InMoment Launches CX Industry’s First Innovations Leveraging ChatGPT in the XI Platform to Solve Real-World Business Challenges for Clients

Distill hundreds of individual customer comments into an easy to understand short overview of the…

AM Best Affirms Credit Ratings of China Taiping Insurance (Macau) Company Limited

HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the…

VinFast will deliver the first VF 9 batch on March 27, 2023

HANOI, VIETNAM - Media OutReach - 23 March 2023 - VinFast announced it will officially…

The Fed raises interest rates despite the ongoing banking crisis

On Wednesday, 22 March 2023, the Federal Reserve continued its fight against inflation and once…

Bybit Goes Live With ARB Token and a $400K Prize Pool

DUBAI, UNITED ARAB EMIRATES - Media OutReach - 23 March 2023 - Bybit, the world's…

Tanoto Foundation and Tsinghua University Launch First-Ever Bilateral Medical Scholarship

The bilateral medical scholarship between the National University of Singapore and Tsinghua University will be…

Thailand Data Center Portfolio Report 2023: Current IT Load Capacity 2022 & Future Capacity Additions 2023-2025 – Analysis of 28 Existing Data Centers & 14 Upcoming Data Centers – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Thailand: Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's…

New Research Finds Majority of US and UK Consumers Believe Economy Won’t Improve in 2023; Shoppers Reducing Spend in Half of Retail Categories

Study reveals consumers will make purchasing decisions based on emotional connection and price relief through…

Renesas’ New RZ/T2L Industrial MPU Enables Fast and Accurate Real-Time Control with EtherCAT Communication

Software Compatibility with Other Renesas MPUs/MCUs Allows Developers to Seamlessly Implement Scalable Design TOKYO--(BUSINESS WIRE)--#Renesas--Renesas…

OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia

Phase 1 trial of OLX72021 has been approved for initiation in Australia OliX will evaluate…